The health service's vaccination scheme will also include a rollout of flu and Covid-19 vaccines. 'Vitally important' Dr ...

The drug, nirsevimab, was effective against respiratory syncytial virus infections when used in the Yukon-Kuskokwim Delta, a ...

COVID-19, influenza, and respiratory syncytial virus (RSV) vaccination coverage is low among adults so far this respiratory virus season (2024 to 2025).

The NHS has encouraged eligible people to get vaccinated against respiratory syncytial virus (RSV). RSV infections can be ...

Learn about this vaccine that protects against a common seasonal virus that can sometimes cause severe disease, with info on ...

Cases of RSV and flu are ticking up among young children in the U.S. even as overall respiratory virus activity remains low, ...

Although the FDA has expanded approvals for two respiratory syncytial virus (RSV) vaccines to include high-risk young and ...

The goal is to "create a vaccine that prevents the most severe disease manifestations that result in hospitalization or death ...

GSK said on Friday that its respiratory syncytial virus (RSV) vaccine has received approval in Japan for expanded use in ...

COVID-19, influenza, and RSV vaccination coverage is low among nursing home residents early in the 2024 to 2025 season.